NO20041573L - Aralkyl-tetrahydro-pyridiner, deres fremstilling og farmasoytiske preparater inneholdende de samme - Google Patents

Aralkyl-tetrahydro-pyridiner, deres fremstilling og farmasoytiske preparater inneholdende de samme

Info

Publication number: NO20041573L
Authority: NO; Norway
Prior art keywords: preparation; pyridines; tetrahydro; aralkyl; same
Prior art date: 2001-10-18

Application number

NO20041573A

Other languages

English (en)

Other versions

NO326490B1 (no

Inventor

Marco Baroni

Pierre Casellas

Bernard Bourrie

Rosanna Cardamone

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-18

Filing date

2004-04-16

Publication date

2004-07-07

2004-04-16 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2004-07-07 Publication of NO20041573L publication Critical patent/NO20041573L/no

2008-12-15 Publication of NO326490B1 publication Critical patent/NO326490B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Ophthalmology & Optometry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)

NO20041573A 2001-10-18 2004-04-16 Aralkyl-tetrahydro-pyridiner, deres fremstilling og anvendelse,og farmasoytiske preparater og medikamenter inneholdende de samme NO326490B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0113469A FR2831166B1 (fr)	2001-10-18	2001-10-18	Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
PCT/FR2002/003508 WO2003033466A1 (fr)	2001-10-18	2002-10-14	Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number	Publication Date
NO20041573L true NO20041573L (no)	2004-07-07
NO326490B1 NO326490B1 (no)	2008-12-15

Family

ID=8868455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041573A NO326490B1 (no)	2001-10-18	2004-04-16	Aralkyl-tetrahydro-pyridiner, deres fremstilling og anvendelse,og farmasoytiske preparater og medikamenter inneholdende de samme

Country Status (21)

Country	Link
US (2)	US7326723B2 (no)
EP (1)	EP1438291B1 (no)
JP (2)	JP4524107B2 (no)
KR (1)	KR100935787B1 (no)
CN (2)	CN100335464C (no)
AT (1)	ATE303991T1 (no)
AU (1)	AU2002360117B2 (no)
BR (1)	BR0213359A (no)
CA (1)	CA2460822C (no)
DE (1)	DE60206068T2 (no)
EA (1)	EA007324B1 (no)
FR (1)	FR2831166B1 (no)
HU (1)	HUP0401713A3 (no)
IL (2)	IL160820A0 (no)
IS (1)	IS2486B (no)
MX (1)	MXPA04003568A (no)
NO (1)	NO326490B1 (no)
NZ (1)	NZ531846A (no)
PL (1)	PL368802A1 (no)
WO (1)	WO2003033466A1 (no)
ZA (1)	ZA200402059B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA04003480A (es)	2001-10-15	2004-07-30	Janssen Pharmaceutica Nv	Derivados de 4-fenil-4-(1h-imidazol-2-il)-piperidina sustituida para la reduccion de la lesion isquemica.
CN100526301C (zh) *	2003-12-26	2009-08-12	卫材R&D管理有限公司	1,2-二(环式基)取代苯化合物
US7410971B2 (en)	2003-12-26	2008-08-12	Eisai R&D Management Co., Ltd.	1,2-di(cyclic)substituted benzene compounds
US20060276465A1 (en) *	2003-12-26	2006-12-07	Eisai R&D Management Co., Ltd.	1,2-di(cyclic) substituted benzene compounds
MY140489A (en) *	2003-12-26	2009-12-31	Eisai R&D Man Co Ltd	1,2-di (cyclic) substituted benzene compounds
AU2005320217B2 (en)	2004-12-20	2011-11-10	Eisai R & D Management Co., Ltd.	Crystal and salt of 1-cyclopropylmethyl-4-[2-(3,3,5,5)-tetramethylcyclohexyl)phenyl]piperazine
MY144974A (en) *	2005-06-14	2011-11-30	Eisai R&D Man Co Ltd	1,2-di(cyclic) substituted benzene derivatives
US8298683B2 (en) *	2005-09-15	2012-10-30	Lg Chem, Ltd.	Organic compound and organic light emitting device using the same
US9608205B2 (en)	2005-09-15	2017-03-28	Lg Chem, Ltd.	Organic compound and organic light emitting device using the same
US9493383B2 (en)	2005-09-15	2016-11-15	Lg Chem, Ltd.	Organic compound and organic light emitting device using the same
WO2009149363A1 (en) *	2008-06-05	2009-12-10	Medical College Of Wisconsin, Inc.	Three dimensional tissues for high-throughput assays

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3804878A (en) *	1969-09-08	1974-04-16	Ciba Geigy Corp	Hydrogenated araliphatic acids
EP0447116B1 (en) *	1990-03-12	1994-12-14	Yamanouchi Pharmaceutical Co. Ltd.	Urea derivatives, their production, and pharmaceutical compositions containing them
FR2662442A1 (fr) *	1990-05-23	1991-11-29	Midy Spa	Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
ATE199721T1 (de) *	1994-07-04	2001-03-15	Takeda Chemical Industries Ltd	Phosphonsäure verbindungen imre herstellung und verwendung
FR2734819B1 (fr) *	1995-05-31	1997-07-04	Adir	Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2762514B1 (fr) *	1997-04-29	1999-10-22	Sanofi Sa	Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments pour le traitement des maladies entrainant une demyelinisation
FR2763847B1 (fr) *	1997-05-28	2003-06-06	Sanofi Sa	Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US6070784A (en) *	1998-07-08	2000-06-06	The Boeing Company	Contact backup roller approach to FSW process
BR0014871A (pt) *	1999-10-22	2002-06-11	Sanofi Synthelabo	Fenil- e piridil-tetrahidro-piridinas que possuem uma atividade inibidora de fnt
PL355502A1 (en) *	1999-12-30	2004-05-04	H.Lundbeck A/S	4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
FR2803593B1 (fr) *	2000-01-06	2002-02-15	Sanofi Synthelabo	Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2823749B1 (fr) *	2001-04-20	2004-02-20	Sanofi Synthelabo	Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant
US7186720B2 (en) *	2001-04-20	2007-03-06	Sanofi-Aventis	Tetrahydropyridyl-alkyl-heterocycles, method for preparing the same and pharmaceutical compositions containing the same
JP3687912B2 (ja) *	2002-08-29	2005-08-24	東芝テック株式会社	プリンタユニット

2001
- 2001-10-18 FR FR0113469A patent/FR2831166B1/fr not_active Expired - Fee Related
2002
- 2002-10-14 JP JP2003536206A patent/JP4524107B2/ja not_active Expired - Fee Related
- 2002-10-14 CA CA2460822A patent/CA2460822C/en not_active Expired - Fee Related
- 2002-10-14 AU AU2002360117A patent/AU2002360117B2/en not_active Ceased
- 2002-10-14 EA EA200400323A patent/EA007324B1/ru not_active IP Right Cessation
- 2002-10-14 CN CNB028207548A patent/CN100335464C/zh not_active Expired - Fee Related
- 2002-10-14 US US10/492,770 patent/US7326723B2/en not_active Expired - Fee Related
- 2002-10-14 PL PL02368802A patent/PL368802A1/xx not_active IP Right Cessation
- 2002-10-14 EP EP02795311A patent/EP1438291B1/fr not_active Expired - Lifetime
- 2002-10-14 NZ NZ531846A patent/NZ531846A/en not_active IP Right Cessation
- 2002-10-14 WO PCT/FR2002/003508 patent/WO2003033466A1/fr not_active Ceased
- 2002-10-14 AT AT02795311T patent/ATE303991T1/de not_active IP Right Cessation
- 2002-10-14 IL IL16082002A patent/IL160820A0/xx unknown
- 2002-10-14 BR BR0213359-8A patent/BR0213359A/pt not_active Application Discontinuation
- 2002-10-14 KR KR1020047005587A patent/KR100935787B1/ko not_active Expired - Fee Related
- 2002-10-14 MX MXPA04003568A patent/MXPA04003568A/es active IP Right Grant
- 2002-10-14 CN CNA2007101368627A patent/CN101096337A/zh active Pending
- 2002-10-14 HU HU0401713A patent/HUP0401713A3/hu unknown
- 2002-10-14 DE DE60206068T patent/DE60206068T2/de not_active Expired - Lifetime
2004
- 2004-03-10 IL IL160820A patent/IL160820A/en not_active IP Right Cessation
- 2004-03-11 IS IS7181A patent/IS2486B/is unknown
- 2004-03-15 ZA ZA200402059A patent/ZA200402059B/en unknown
- 2004-04-16 NO NO20041573A patent/NO326490B1/no not_active IP Right Cessation
2007
- 2007-12-18 US US11/958,476 patent/US7858824B2/en not_active Expired - Fee Related
2010
- 2010-02-18 JP JP2010033642A patent/JP2010120961A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
IL160820A0 (en)	2004-08-31
WO2003033466A1 (fr)	2003-04-24
KR20050036866A (ko)	2005-04-20
IL160820A (en)	2009-06-15
US7858824B2 (en)	2010-12-28
EP1438291B1 (fr)	2005-09-07
ATE303991T1 (de)	2005-09-15
IS7181A (is)	2004-03-11
JP4524107B2 (ja)	2010-08-11
CN1571770A (zh)	2005-01-26
ZA200402059B (en)	2005-03-15
FR2831166A1 (fr)	2003-04-25
KR100935787B1 (ko)	2010-01-06
DE60206068T2 (de)	2006-07-13
MXPA04003568A (es)	2004-07-30
HUP0401713A3 (en)	2012-08-28
FR2831166B1 (fr)	2004-02-27
EP1438291A1 (fr)	2004-07-21
CA2460822A1 (en)	2003-04-24
CN101096337A (zh)	2008-01-02
JP2010120961A (ja)	2010-06-03
CN100335464C (zh)	2007-09-05
US20080097117A1 (en)	2008-04-24
AU2002360117B2 (en)	2008-07-17
HK1065543A1 (en)	2005-02-25
IS2486B (is)	2008-12-15
JP2005505621A (ja)	2005-02-24
BR0213359A (pt)	2004-10-26
EA007324B1 (ru)	2006-08-25
US7326723B2 (en)	2008-02-05
HUP0401713A2 (hu)	2004-12-28
NO326490B1 (no)	2008-12-15
PL368802A1 (en)	2005-04-04
CA2460822C (en)	2011-01-04
EA200400323A1 (ru)	2004-10-28
NZ531846A (en)	2005-10-28
US20050014795A1 (en)	2005-01-20
DE60206068D1 (de)	2005-10-13

Publication	Publication Date	Title
MXPA02012033A (es)	2003-04-25	Derivados de 2-aminocarbonil-9h-purina.
EA200200940A1 (ru)	2003-02-27	Производные азетидина, способ их получения и содержащие их фармацевтические композиции
EA200100972A1 (ru)	2002-02-28	Новые соединения и композиции как ингибиторы протеаз
WO2002048157A3 (en)	2003-03-27	Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
NO993996L (no)	1999-10-18	N-heterosykliske derivater som NOS-inhibitorer
NZ536734A (en)	2006-03-31	Spiroindolinepiperidine derivatives
EA200201264A1 (ru)	2003-04-24	5-хлор-3(4-метансульфонилфенил)-6'-метил-[2,3']бипиридинил в чистой кристаллической форме и способ синтеза
EA200200774A1 (ru)	2003-02-27	Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции
NO20043016L (no)	2004-07-15	6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
NO20041573L (no)	2004-07-07	Aralkyl-tetrahydro-pyridiner, deres fremstilling og farmasoytiske preparater inneholdende de samme
UA83648C2 (ru)	2008-08-11	Антагонисты аденозиндифосфатного рецептора тромбоцитов
EA200301203A1 (ru)	2004-04-29	Новые соединения и композиции как ингибиторы катепсина
ATE482933T1 (de)	2010-10-15	Sulfopyrrolderivate
EA200300044A1 (ru)	2003-06-26	Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
BR0318521A (pt)	2006-09-12	arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
UA66866C2 (uk)	2004-06-15	Синтез морфолінових похідних
TR200503401T1 (tr)	2008-03-21	Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
DE60227421D1 (de)	2008-08-14	Rmazeutische zusammensetzung und verwendung davon
WO2003080631A3 (en)	2004-04-15	Plasma carboxypeptidase b inhibitors
SE9904128D0 (sv)	1999-11-15	Novel compounds
EA200201024A1 (ru)	2003-02-27	Фармацевтические композиции, содержащие олигосахариды, и их получение
DE502004009136D1 (de)	2009-04-23	NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb
EA200300400A1 (ru)	2003-10-30	17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
DK1250335T3 (da)	2005-11-14	Fremgangsmåde og mellemprodukter til fremstilling af imidazopyridiner
HUP0401895A2 (hu)	2004-12-28	Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date	Code	Title	Description
2013-05-27	MM1K	Lapsed by not paying the annual fees